Open access
Sep 2026
Tarlatamab: Invaluable Time for Patients With Extensive-Stage Small Cell Lung Cancer.
Tarlatamab-dlle (tarlatamab), a bispecific T-cell engager targeting delta-like ligand 3, offers a novel therapeutic option f.
Elizabeth Jane Entrop, Casey B. Brown
· Clinical Journal of Oncology... · 0 citations